UPC_CFI_14/2023

ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

InfringementMain Infringement ActionMunich LDInfringementWritten Phase

2023-07-17-ld-munich-upc_cfi_14-2023-ord_551192-2023-app_459916-2023-abtrennung-anonymized.pdf2023-07-17DE
2023-07-28-ld-munich-upc_cfi_14-2023-ord_556750-2023-app_459916-2023-keine-abtrennung-anonymized.pdf2023-07-28DE
2023-08-16-ld-munich-upc_cfi_14-2023-ord_562104-2023-app_459916-2023-verfahrensleitende-vfg.anoymized.pdf2023-08-16DE
2023-08-17-ld-munich-ord-562104-2023-upc-cfi-14-2023-459916-2023-verf.l.vfg_.-anonymized.pdf2023-08-17DE
2023-11-03-ld-munich-upc_cfi_14-2023-ord_584907-2023-act_4599162023-wechsel-der-verfahrenssprache-anonymized.pdf2023-11-03DE
2024-01-02%20LD%20Munich%20UPC_CFI_14%20ORD_597730-2023%20ACT_459916-2023%20anonymized_0.pdf2024-01-02EN
2024-01-02%20LD%20Munich%20UPC_CFI_14-2023%20ORD_597730-2023%20ACT_459916-2023%20anonymized%20%281%29.pdf2024-01-02EN
2024-01-02%20LD%20Munich%20UPC_CFI_14-2023%20ORD_597730-2023%20ACT_459916-2023%20anonymized.pdf2024-01-02EN
2024-02-02%20LD%20Munich%20UPC_CFI%2014-2023%20ORD_392-2024%20ACT_459916-2023%20anonymized.pdf2024-02-02EN
23-08-17-ld-munich-ord-562104-2023-upc-cfi-14-2023-459916-2023-verf.l.vfg_.-anonymized_0.pdf2023-08-17DE
23-08-29-ld-munich-ord-566193-2023-upc-cfi-14-2023-459916-2023-fristen-anonymized.pdf2023-08-29DE